服用“纯中药”制剂的癫痫患者抗癫痫药血药浓度监测  被引量:3

Monitoring of Antiepileptic Western Drugs in Blood of Epileptic Patients Receiving So-called Antiepileptic"Pure Chinese Traditional Medicine"Preparations

在线阅读下载全文

作  者:王锦秋[1] 梁维薇[1] 丰艳梅[1] 

机构地区:[1]西安交通大学医学院第二附属医院药剂科,西安710004

出  处:《中国药师》2008年第5期521-523,共3页China Pharmacist

基  金:陕西省科学技术研究发展计划项目[编号:2006k14-G5(3)]

摘  要:目的:了解某些抗癫痫"纯中药"制剂中是否含有抗癫痫西药成分,为临床合理用药提供依据。方法:对服用"纯中药"制剂的30例癫痫患者,用荧光偏振免疫法(FPIA)筛检其是否含有丙戊酸(VPA)、卡马西平(CBZ)、苯巴比妥(PB)、苯妥英钠(DPA)等4种常用抗癫痫西药。结果:30例患者中,检测出上述1~4种常用抗癫痫西药的28例,占93.3%。其中VPA 16例,平均浓度(12.02±14.97)μg·ml^(-1);CBZ 20例,平均浓度(2.43±2.54)μg·ml^(-1);PB 23例,平均浓度(14.57±16.63)μg·ml^(-1);DPA 22例,平均浓度(7.31±13.43)μg·ml^(-1)。结论:在所谓的抗癫痫"纯中药"制剂中暗加西药较普遍,严重侵犯了患者知情权,妨碍了抗癫痫的正规治疗,有损患者健康。Objective: To understand and prove whether some antiepileptic "pure Chinese Traditional medicine" preparations containing antiepileptic western drug ingredients in order to provide a theory and experimental basis for clinical drug-use safely and reasonable. Method: The Thirty cases with epileptics, who had took the antiepileptic "pure Chinese medicine" preparations were monitored for blood concentrations of VPA, CBZ, PB and DPA by FPIA. Result: Thirty patients with epilepsy taken "pure Chinese Traditional medicine", preparations were examined and one to four kinds of antiepileptic drugs were found in their serum for 28 patients (93.3%). Patients containing VPA, CBZ, PB, DPA were 16, 20, 23 and 22 respectively. The average blood concentration of VPA, CBZ, PB, DPA were ( 12.02 ± 14.97 ) μm·ml^-1, ( 2.43 ± 2. 54 ) μm·ml^-1 , ( 14.57 ± 16.63 ) μm·ml^-1 and ( 7.31 ± 13.43 ) μm·ml^-1 , respectively. Conclusion: It is ,very common that antiepileptic western drugs were added in "pure Chinese Traditional medicine" preparations, which violates the patients with standard therapy and does harm to their health.

关 键 词:中药 抗癫痫药 血药浓度监测 

分 类 号:R97[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象